PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Menopause The Journal of The North American Menopause Society0 citations

Women, menopause, hormone therapy, and cardiovascular disease: what WHI still teaches us in 2025, and where are we now?

View Full Paper
MCMarianne Canonico

Key Points

  • Hormone therapy influences cardiovascular disease risk in women, showing complex relationships.
  • The Women's Health Initiative data reveals critical insights that remain relevant in 2025 for managing cardiovascular health.
  • Observational analysis highlights menopausal impacts on cardiovascular health and how interventions can mitigate risks.
  • This study underscores the need for nuanced approaches to hormone therapy and cardiovascular care among women, emphasizing personalized health strategies.

Abstract

International audience

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Marianne Canonico (2026) studied this question.

synapsesocial.com/papers/69a75d3cc6e9836116a26ee4https://doi.org/10.1097/gme.0000000000002735
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 20212024 · 2,759 citations
  2. 2Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein2008 · 6,715 citations
  3. 3Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial2002 · 15,926 citations
  4. 4Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism2009 · 266 citations
  5. 5Baseline use of aspirin or statins with oral estrogen and progestogens to prevent incident arterial or venous thrombotic events: a secondary analysis of the Women’s Health Initiative trial2025 · 3 citations